Brief: Xvivo Q3 EBIT SEK 20.5 Million
Oct 24 (Reuters) - Xvivo Q3 sales SEK 198.5 million vs. IBES estimate SEK 208.2 million. * Q3 adjusted EBIT SEK 25.5 million * Q3 EPS SEK 2.72 * Q3 net income SEK 85.8 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength